Psychedelic Bulletin: COMPASS Targets PTSD; Detroit Decriminalizes Psychedelics; We Speak to...

PharmaDrug Advances Psychedelics Program with Analogue DMT Formulations to Treat Eye...

MindMed Appoints Dr. Maria Oquendo to its Scientific Advisory Board

PT270 – Dr. Rachel Yehuda – Research Trials and The Future...

Complete Results from Red Light Oregon Market Research in Oregon Show...

Cybin Granted DEA Schedule I Manufacturing License

MINDCURE Provides Update on Studies and Clinical Trials

The Missing Mushroom: Psychedelic Science and the Future of Psilocybin

COMPASS Pathways to launch phase II trial of COMP360 psilocybin therapy...

Mydecine Files Full Patent Application Covering New Formulations that Bring Nanoemulsion...

Load more